Biotech company Moderna has said it will submit its Covid-19 vaccine candidate for emergency approval in the US and Europe after stage three trials concluded with positive results.

In a statement released on Monday, Moderna said that its vaccine has proven to be extremely effective against Covid-19.

According to the firm, final analysis from the trial shows their jab was 94.1 percent effective in stopping Covid-19 infections. (RT)